Back to Research Home
CSLCarlisle Companies Incorporated
Consumer Discretionary · Specialty Chemicals · Large
$345.04−2.14%
As of 23 Oct 2026Mkt cap $13.6B
Stage 13
WAIT
Fundamentals
48.5/75
Technical
12.0/15
Independent
60.5/90
GCAE viewelevated earnings event risk blocks an independent BUY decision
Price
- 1M
- +9.8%
- 3M
- +1.3%
- 6M
- −4.2%
- 1Y
- +4.0%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 19.8xHist median 16.6x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 17.2x
- FCF yield
- 5.8%
Quality
- ROIC
- 21.1%
- Operating margin
- 21.4%
- FCF margin
- 19.3%
- Current ratio
- 3.1x
Growth
- Revenue growth
- +0.3%Latest FY YoY
- Revenue CAGR
- +7.0%
- EPS CAGR
- +21.3%
- FCF CAGR
- +35.6%
Capital
- Share-count trend
- −7.4%3Y annualised
- Net debt
- $1.9B1.7x OCF
Annual trend
- CAGR 2021–2025
- +7.0%
- Latest · 2025
- $5B
- YoY
- +0.3%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- FUNDAMENTAL GATE FAIL
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
elevated earnings event risk blocks an independent BUY decision
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-10-28
More details & evidence
Production decision
- Stage 13
- WAIT
- Technical state
- early-recovery
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded